DOSSIER · 13F Holders · Q3 2026
BBIO 2.25 02/01/29
BRIDGEBIO PHARMA INC
50 institutions still hold BRIDGEBIO PHARMA INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 10806XAD4·50 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
50 institutions reported BBIO 2.25 02/01/29 in Q3 2026. VOYA INVESTMENT MANAGEMENT LLC leads at 32.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
30 more holders available. Log in →